PCN52 BUDGET IMPACT OF SUBA-ITRACONAZOLE CAPSULES (SUBA-ITRA) FOR THE TREATMENT OF SYSTEMIC MYCOSES IN THE U.S

Autor:	G. Lewis, M. Dolph, D. Newman, Gabriel Tremblay, T. Westley
Rok vydání:	2019
Předmět:	Toxicology business.industry Health Policy Public Health Environmental and Occupational Health Medicine SUBA-Itraconazole Budget impact business
Zdroj:	Value in Health. 22:S65
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.04.176
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0c4af181d11a78b0a1839cc2ea1dbb20 https://doi.org/10.1016/j.jval.2019.04.176 Zobrazit plný text záznamu Full Text from ScienceDirect